Healthcare - Pharma & Biotech

Total Market Cap 3,635.3B
P/E (Weighted)Price to Earnings ratio. 42.79 Medyan: 25.00
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 5.00
P/E (Arithmetic)Simple average P/E. 32.60
Avg Lothien ScoreFinancial health score (0-100). 59
Avg DamodaranDamodaran scoring model. 53
Avg PotentialExpected upside potential %. +2.7%
Avg Dalio ScoreDalio debt cycle score. 71
Distributions
Lothien Distribution
0–25
0
25–40
0
40–55
5
55–70
6
70–100
2
Damodaran Distribution
0–25
0
25–40
2
40–55
6
55–70
4
70–100
1
Upside Potential
-100% – -20%
4
-20% – +0%
2
+0% – +20%
2
+20% – +50%
5
+50%+
0
Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
INCY
128.32 26.0B 18.17 4.63 12.07 58.2% 9.2% 79 71 176.70 +28.3% 95 0.01
REGN
841.96 85.2B 18.90 2.72 14.56 9.7% 8.5% 72 50 1,199.50 +31.9% 97 0.09
BMY
67.64 138.2B 19.61 7.45 11.64 14.9% 7.1% 69 69 102.64 +37.3% 54 2.75
GILD
150.24 186.3B 22.97 8.65 14.91 23.9% 8.1% 69 65 169.70 +9.7% 73 1.16
MRK
151.11 372.8B 20.42 7.19 14.32 25.6% 8.1% 65 63 160.15 +4.5% 80 0.80
PFE
28.67 163.4B 21.03 1.76 12.02 8.0% 7.5% 63 52 47.29 +46.7% 54 0.66
BIIB
224.43 33.2B 39.73 1.76 18.81 5.5% 7.9% 61 49 332.93 +34.8% 64 0.44
JNJ
278.01 670.0B 25.00 8.45 17.53 15.2% 8.2% 58 50 234.87 -11.2% 74 0.58
AMGN
443.41 239.7B 31.10 24.92 17.24 13.0% 7.9% 54 51 377.30 -10.7% 52 5.67
ALNY
265.96 35.6B 44.05 26.28 29.80 101.3% 9.5% 50 48 126.45 -39.3% 82 0.94
VRTX
556.57 141.1B 38.39 8.15 29.59 -0.5% 8.6% 49 27 361.54 -24.2% 95 0.11
LLY
1,150.50 1,083.0B 52.48 45.52 44.11 36.0% 8.5% 42 38 454.39 -45.4% 70 1.79
ABBV
260.83 460.9B 100.00 40.96 18.8% 8.0% 41 58 148.69 -27.5% 40 -26.02

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.

A
AirSelim
Online
A
Hello! I am AirSelim, your Lothien finance assistant.

I can answer questions about market data, news, technical analysis, portfolio analysis and more.

I cover 26 exchanges (BIST, US, LSE, Xetra, Tadawul, KASE and others) — plus crypto.